Japanese pharmaceutical companies – some of the most sophisticated and cash-rich in the world – are shopping abroad for targets to enrich their drug pipelines and counter the uncertain outlook for sales in Japan. But sellers are still insisting on hefty price-tags, despite slowing economic growth and depressed equity markets.
¬ Haymarket Media Limited. All rights reserved.
